Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer

Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer

BACKGROUND: Superior sulcus tumours (SSTs) are relatively uncommon and one of the most intractable lung cancers among non-small cell lung cancer (NSCLC). We planned a multicenter, single-arm confirmatory trial of new multidisciplinary treatment using immune-checkpoint inhibitor. The aim is to evalua...

Full description

Bibliographic Details
Main Authors: Aokage, K. (Author), Fukuda, H. (Author), Fukutani, M. (Author), Horinouchi, H. (Author), Ishikura, S. (Author), Kanato, K. (Author), Kataoka, T. (Author), Koyama, S. (Author), Kumagai, S. (Author), Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group (Author), Nakamura, N. (Author), Nishikawa, H. (Author), Ohe, Y. (Author), Tsuboi, M. (Author), Wakabayashi, M. (Author), Watanabe, S.-I (Author), Zenke, Y. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Antibodies, Monoclonal
cancer staging
Carcinoma, Non-Small-Cell Lung
chemoradiotherapy
Chemoradiotherapy
durvalumab
human
Humans
immune-checkpoint inhibitor
Lung Neoplasms
lung tumor
monoclonal antibody
Multicenter Studies as Topic
multicenter study (topic)
multidisciplinary
Neoplasm Staging
non small cell lung cancer
Pancoast
pathology
procedures
Prospective Studies
prospective study
superior sulcus tumour
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items